Phase 4
N=183
Spinal Anesthesia With Hyperbaric Levobupivacaine 0.75% for Ambulatory Knee Arthroscopy
Disorder of Knee · Anesthesia
Bottom Line
View on ClinicalTrials.gov: NCT01881087 ↗Enrolled (actual)
183
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Probability of Motor Block — 5; 20; 27 percentage of motor block
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Hyperbaric Levobupivacaine 0.75% (Drug)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Fundacion Clinica Valle del Lili
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Probability of Motor Block |
5; 20; 27 | — |
| SECONDARY Failed Spinal Block Rate |
2; 3; 1 | — |
Summary
The purpose of this study is to evaluate motor block probability throughout time and clinical profile when using three different doses of HLBP 0.75% (7.5, 9.37 and 11.25 mg) by a unilateral spinal block technique.
Eligibility Criteria
Inclusion Criteria
- Patients aged 18-64 y.o. scheduled for knee arthroscopy (therapeutic or diagnostic)
Exclusion Criteria
- Cardiac or pulmonary disease
- Antiplatelet or anticoagulant drugs use during 7 days before surgery
- History of coagulative disorders
- Bilateral procedures
Data sourced from ClinicalTrials.gov (NCT01881087). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.